Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Dreher

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2022
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell LymphomaAndreas K Buck, Götz Ulrich Grigoleit, Sabrina Kraus, et al.
Molecular Imaging and Biology|August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone LymphomaRudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2023
CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathologyNiklas Dreher, Stefanie Hahner, Carmina T Fuß, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2022
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell LymphomaAndreas K Buck, Götz Ulrich Grigoleit, Sabrina Kraus, et al.
Molecular Imaging and Biology|August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone LymphomaRudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2023
CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathologyNiklas Dreher, Stefanie Hahner, Carmina T Fuß, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Pageof 2